Suchergebnisse - "CPX-351"

PubPharm (180)

1

CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis

enthalten in: Blood | 2024

von Renga, G. | Nunzi, E. | Stincardini, C. | +12

2

Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML

enthalten in: Leukemia | 2024

von Shimony, S. | Bewersdorf, J. | Shallis, R. | +15

3

A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia

enthalten in: International journal of hematology | 2024

von Usuki, K. | Miyamoto, T. | Yamauchi, T. | +49

4

Phase 1/2 study of CPX-351 for patients with Int-2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents

enthalten in: British journal of haematology | 2024

von Montalban-Bravo, G. | Jabbour, E. | Borthakur, G. | +13

5

CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment : Phase 1 Trial

enthalten in: Cancers | 2024

von Solomon, S. | Powell, B. | Koprivnikar, J. | +10

6

CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial

in: Cancers | 2024

von Scott R. Solomon | Bayard L. Powell | Jamie Koprivnikar | +10

7

CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature

in: Frontiers in Oncology | 2024

von Alessandra Sperotto | Maria Teresa Lupo Stanghellini | Jacopo Peccatori | +8

8

Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old : a retrospective analysis from the PETHEMA registry

enthalten in: Haematologica | 2024

von Martínez-Cuadrón, D. | Megías-Vericat, J. | Gil, C. | +32

9

Case Report of a DDX41 Germline Mutation in a Family with Multiple Relatives Suffering from Leukemia

enthalten in: Biomedicines | 2023

von Wagner, J. | Al-Bazaz, M. | Forstreuter, A. | +5

10

A new sequential conditioning regimen based on CPX- 351/Vyxeos ("Vyx-Seq") in patients with higher risk myelodysplastic syndromes

enthalten in: Leukemia research | 2023

von Notarantonio, A. | Roth-Guépin, G. | Bonmati, C. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]